{"id":23741,"date":"2021-07-15T12:00:00","date_gmt":"2021-07-15T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/"},"modified":"2026-08-20T07:35:50","modified_gmt":"2026-08-20T07:35:50","slug":"mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/","title":{"rendered":"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1246 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Le mois dernier, EUFOREA a consacr\u00e9 une \u00e9mission \u00e0 la mise \u00e0 jour 2021 de la GINA (Global Initiative for Asthma) et a re\u00e7u une r\u00e9ponse incroyable, avec des milliers de personnes ayant regard\u00e9 cette \u00e9mission. Dans cette \u00e9mission t\u00e9l\u00e9vis\u00e9e d\u2019actualit\u00e9 de derni\u00e8re minute, nous souhaitons consacrer un peu plus de temps \u00e0 l\u2019examen de la mise \u00e0 jour 2021 de la GINA sous une perspective moyen-orientale. <\/p>\n<p>L\u2019OMS (Organisation mondiale de la Sant\u00e9) reconna\u00eet que l\u2019asthme rev\u00eat une importance majeure en mati\u00e8re de sant\u00e9 publique. Selon l\u2019OMS, on estimait que plus de 339 millions de personnes souffraient d\u2019asthme dans le monde et que 417\u202f918 d\u00e9c\u00e8s \u00e9taient dus \u00e0 l\u2019asthme \u00e0 l\u2019\u00e9chelle mondiale en 2016. La GINA est une strat\u00e9gie mondiale de prise en charge de l\u2019asthme, fond\u00e9e sur la litt\u00e9rature scientifique r\u00e9cente, \u00e9labor\u00e9e par un panel international d\u2019experts au sein du comit\u00e9 scientifique de la GINA.  <\/p>\n<p>D\u00e9couvrez-en davantage sur la prise en charge et la pr\u00e9vention de l\u2019asthme, les diff\u00e9rents traitements biologiques et la mani\u00e8re dont la GINA 2021 peut \u00eatre mise en \u0153uvre dans la vie r\u00e9elle, compte tenu de la grande quantit\u00e9 de nouvelles informations fournies, alors que nous interviewons la professeure Mona Al-Ahmad, allergologue consultante senior et sp\u00e9cialiste en immunologie clinique au Al-Rashed Allergy Centre, Kowe\u00eft City, Kowe\u00eft. Vous d\u00e9couvrirez \u00e9galement quels sont les principaux points forts et les progr\u00e8s r\u00e9alis\u00e9s dans la GINA 2021, ainsi qu\u2019un domaine d\u2019am\u00e9lioration suppl\u00e9mentaire de la GINA au-del\u00e0 de 2021. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1247 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/kjnp4ptjQk8?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le mois dernier, EUFOREA a consacr\u00e9 une \u00e9mission \u00e0 la mise \u00e0 jour 2021 de la GINA (Global Initiative for Asthma) et a re\u00e7u une r\u00e9ponse incroyable, avec des milliers de personnes ayant regard\u00e9 cette \u00e9mission. Dans cette \u00e9mission t\u00e9l\u00e9vis\u00e9e d\u2019actualit\u00e9 de derni\u00e8re minute, nous souhaitons consacrer un peu plus de temps \u00e0 l\u2019examen de la mise \u00e0 jour 2021 de la GINA sous une perspective moyen-orientale. L\u2019OMS (Organisation mondiale de la Sant\u00e9) reconna\u00eet que l\u2019asthme rev\u00eat une importance majeure en mati\u00e8re de sant\u00e9 publique. Selon l\u2019OMS, on estimait que plus de 339 millions de personnes souffraient d\u2019asthme dans le monde et que 417\u202f918 d\u00e9c\u00e8s \u00e9taient dus \u00e0 l\u2019asthme \u00e0 l\u2019\u00e9chelle mondiale en 2016. La GINA est une strat\u00e9gie mondiale de prise en charge de l\u2019asthme, fond\u00e9e sur la litt\u00e9rature scientifique r\u00e9cente, \u00e9labor\u00e9e par un panel international d\u2019experts au sein du comit\u00e9 scientifique de la GINA. D\u00e9couvrez-en davantage sur la prise en charge et la pr\u00e9vention de l\u2019asthme, les diff\u00e9rents traitements biologiques et la mani\u00e8re dont la GINA 2021 peut \u00eatre mise en \u0153uvre dans la vie r\u00e9elle, compte tenu de la grande quantit\u00e9 de nouvelles informations fournies, alors que nous interviewons la professeure Mona Al-Ahmad, allergologue consultante senior et sp\u00e9cialiste en immunologie clinique au Al-Rashed Allergy Centre, Kowe\u00eft City, Kowe\u00eft. Vous d\u00e9couvrirez \u00e9galement quels sont les principaux points forts et les progr\u00e8s r\u00e9alis\u00e9s dans la GINA 2021, ainsi qu\u2019un domaine d\u2019am\u00e9lioration suppl\u00e9mentaire de la GINA au-del\u00e0 de 2021.<\/p>\n","protected":false},"author":1,"featured_media":23751,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[172,170,171],"class_list":["post-23741","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-asthme","tag-professionnels-de-sante","tag-actualites-euforea"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II\" \/>\n<meta property=\"og:description\" content=\"Le mois dernier, EUFOREA a consacr\u00e9 une \u00e9mission \u00e0 la mise \u00e0 jour 2021 de la GINA (Global Initiative for Asthma) et a re\u00e7u une r\u00e9ponse incroyable, avec des milliers de personnes ayant regard\u00e9 cette \u00e9mission. Dans cette \u00e9mission t\u00e9l\u00e9vis\u00e9e d\u2019actualit\u00e9 de derni\u00e8re minute, nous souhaitons consacrer un peu plus de temps \u00e0 l\u2019examen de la mise \u00e0 jour 2021 de la GINA sous une perspective moyen-orientale. L\u2019OMS (Organisation mondiale de la Sant\u00e9) reconna\u00eet que l\u2019asthme rev\u00eat une importance majeure en mati\u00e8re de sant\u00e9 publique. Selon l\u2019OMS, on estimait que plus de 339 millions de personnes souffraient d\u2019asthme dans le monde et que 417\u202f918 d\u00e9c\u00e8s \u00e9taient dus \u00e0 l\u2019asthme \u00e0 l\u2019\u00e9chelle mondiale en 2016. La GINA est une strat\u00e9gie mondiale de prise en charge de l\u2019asthme, fond\u00e9e sur la litt\u00e9rature scientifique r\u00e9cente, \u00e9labor\u00e9e par un panel international d\u2019experts au sein du comit\u00e9 scientifique de la GINA. D\u00e9couvrez-en davantage sur la prise en charge et la pr\u00e9vention de l\u2019asthme, les diff\u00e9rents traitements biologiques et la mani\u00e8re dont la GINA 2021 peut \u00eatre mise en \u0153uvre dans la vie r\u00e9elle, compte tenu de la grande quantit\u00e9 de nouvelles informations fournies, alors que nous interviewons la professeure Mona Al-Ahmad, allergologue consultante senior et sp\u00e9cialiste en immunologie clinique au Al-Rashed Allergy Centre, Kowe\u00eft City, Kowe\u00eft. Vous d\u00e9couvrirez \u00e9galement quels sont les principaux points forts et les progr\u00e8s r\u00e9alis\u00e9s dans la GINA 2021, ainsi qu\u2019un domaine d\u2019am\u00e9lioration suppl\u00e9mentaire de la GINA au-del\u00e0 de 2021.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T07:35:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/\",\"name\":\"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png\",\"datePublished\":\"2021-07-15T12:00:00+00:00\",\"dateModified\":\"2026-08-20T07:35:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/","og_locale":"fr_FR","og_type":"article","og_title":"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II","og_description":"Le mois dernier, EUFOREA a consacr\u00e9 une \u00e9mission \u00e0 la mise \u00e0 jour 2021 de la GINA (Global Initiative for Asthma) et a re\u00e7u une r\u00e9ponse incroyable, avec des milliers de personnes ayant regard\u00e9 cette \u00e9mission. Dans cette \u00e9mission t\u00e9l\u00e9vis\u00e9e d\u2019actualit\u00e9 de derni\u00e8re minute, nous souhaitons consacrer un peu plus de temps \u00e0 l\u2019examen de la mise \u00e0 jour 2021 de la GINA sous une perspective moyen-orientale. L\u2019OMS (Organisation mondiale de la Sant\u00e9) reconna\u00eet que l\u2019asthme rev\u00eat une importance majeure en mati\u00e8re de sant\u00e9 publique. Selon l\u2019OMS, on estimait que plus de 339 millions de personnes souffraient d\u2019asthme dans le monde et que 417\u202f918 d\u00e9c\u00e8s \u00e9taient dus \u00e0 l\u2019asthme \u00e0 l\u2019\u00e9chelle mondiale en 2016. La GINA est une strat\u00e9gie mondiale de prise en charge de l\u2019asthme, fond\u00e9e sur la litt\u00e9rature scientifique r\u00e9cente, \u00e9labor\u00e9e par un panel international d\u2019experts au sein du comit\u00e9 scientifique de la GINA. D\u00e9couvrez-en davantage sur la prise en charge et la pr\u00e9vention de l\u2019asthme, les diff\u00e9rents traitements biologiques et la mani\u00e8re dont la GINA 2021 peut \u00eatre mise en \u0153uvre dans la vie r\u00e9elle, compte tenu de la grande quantit\u00e9 de nouvelles informations fournies, alors que nous interviewons la professeure Mona Al-Ahmad, allergologue consultante senior et sp\u00e9cialiste en immunologie clinique au Al-Rashed Allergy Centre, Kowe\u00eft City, Kowe\u00eft. Vous d\u00e9couvrirez \u00e9galement quels sont les principaux points forts et les progr\u00e8s r\u00e9alis\u00e9s dans la GINA 2021, ainsi qu\u2019un domaine d\u2019am\u00e9lioration suppl\u00e9mentaire de la GINA au-del\u00e0 de 2021.","og_url":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","article_modified_time":"2026-08-20T07:35:50+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/","url":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/","name":"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png","datePublished":"2021-07-15T12:00:00+00:00","dateModified":"2026-08-20T07:35:50+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/202120Update20GINA20-20Global20Initiative20for20Asthma20Part20II.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/mise-a-jour-2021-de-la-gina-initiative-mondiale-pour-lasthme-partie-ii\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Mise \u00e0 jour 2021 de la GINA \u2013 Initiative mondiale pour l\u2019asthme, partie II"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/23741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=23741"}],"version-history":[{"count":1,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/23741\/revisions"}],"predecessor-version":[{"id":24057,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/23741\/revisions\/24057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/23751"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=23741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=23741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=23741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}